Amgen (AMGN) Construction in Progress (2009 - 2022)

Amgen's Construction in Progress history runs 14 years deep, the most recent figure standing at $1.2 billion for Q4 2022.

• In Q4 2022, Construction in Progress rose 22.9% year-over-year to $1.2 billion; the TTM figure through Dec 2022 stood at $1.2 billion (up 22.9% YoY), while the FY2022 annual figure was $1.2 billion, up 22.9% from the prior year.
• Construction in Progress was $1.2 billion for Q4 2022 at Amgen, up from $987.0 million in the prior quarter.
• In the past five years, Construction in Progress ranged from a high of $1.2 billion in Q4 2022 to a low of $907.0 million in Q4 2019.
• Historically, Construction in Progress has averaged $995.0 million across 5 years, with a median of $953.0 million in 2018.
• The sharpest annual moves came in 2019 and 2022: Construction in Progress decreased 4.83% in 2019, then rose 22.9% in 2022.
• A 5-year view of Construction in Progress shows it stood at $953.0 million in 2018, then slipped by 4.83% to $907.0 million in 2019, then advanced by 0.88% to $915.0 million in 2020, then increased by 7.87% to $987.0 million in 2021, then grew by 22.9% to $1.2 billion in 2022.
• The last three Construction in Progress figures came in at $1.2 billion (Q4 2022), $987.0 million (Q4 2021), and $915.0 million (Q4 2020), per Business Quant data.